Ginkgo Bioworks Holdings, Inc. (DNA)
7.11
+0.12
(+1.72%)
USD |
NYSE |
Sep 16, 09:31
Ginkgo Bioworks Holdings Enterprise Value : 523.41M for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 523.41M |
| September 14, 2026 | 524.62M |
| September 11, 2026 | 508.83M |
| September 10, 2026 | 510.66M |
| September 09, 2026 | 511.26M |
| September 08, 2026 | 520.37M |
| September 04, 2026 | 520.98M |
| September 03, 2026 | 520.98M |
| September 02, 2026 | 525.83M |
| September 01, 2026 | 519.76M |
| August 31, 2026 | 512.48M |
| August 28, 2026 | 521.58M |
| August 27, 2026 | 539.80M |
| August 26, 2026 | 537.98M |
| August 25, 2026 | 556.80M |
| August 24, 2026 | 510.66M |
| August 21, 2026 | 548.30M |
| August 20, 2026 | 521.58M |
| August 19, 2026 | 567.12M |
| August 18, 2026 | 495.48M |
| August 17, 2026 | 519.16M |
| August 14, 2026 | 511.26M |
| August 13, 2026 | 538.58M |
| August 12, 2026 | 536.76M |
| August 11, 2026 | 554.98M |
| Date | Value |
|---|---|
| August 10, 2026 | 563.47M |
| August 07, 2026 | 582.90M |
| August 06, 2026 | 615.08M |
| August 05, 2026 | 667.90M |
| August 04, 2026 | 667.90M |
| August 03, 2026 | 641.79M |
| July 31, 2026 | 590.19M |
| July 30, 2026 | 590.19M |
| July 29, 2026 | 561.65M |
| July 28, 2026 | 566.51M |
| July 27, 2026 | 551.33M |
| July 24, 2026 | 545.87M |
| July 23, 2026 | 580.47M |
| July 22, 2026 | 574.40M |
| July 21, 2026 | 578.05M |
| July 20, 2026 | 557.40M |
| July 17, 2026 | 579.26M |
| July 16, 2026 | 602.33M |
| July 15, 2026 | 645.43M |
| July 14, 2026 | 647.86M |
| July 13, 2026 | 648.47M |
| July 10, 2026 | 650.90M |
| July 09, 2026 | 689.75M |
| July 08, 2026 | 649.68M |
| July 07, 2026 | 666.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sotera Health Co. | 7.328B |
| CareDx, Inc. | 2.356B |
| BillionToOne, Inc. | 4.478B |
| Quest Diagnostics, Inc. | 33.32B |
| Labcorp Holdings, Inc. | 32.85B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -57.32M |
| Revenue (Quarterly) | 20.16M |
| Total Expenses (Quarterly) | 77.48M |
| EPS Diluted (Quarterly) | -1.147 |
| Gross Profit Margin (Quarterly) | 30.37% |
| Profit Margin (Quarterly) | -284.4% |
| Earnings Yield | -76.53% |
| Normalized Earnings Yield | -76.50 |